thymus + ligandome: the NOD tissue labels, settled by measurement
Browse filesPXD031966 covers thymus and pancreas and its runs are labelled NOD2_3/NOD4/NOD5, which
name neither. thymus/SOURCES.md carried that as an open problem and withheld the peptides
rather than guess. The re-search settles it.
Searching all nine raw files against the whole mouse proteome -- rather than the deposit's
own predicted-binder FASTA at 5% PSM FDR -- gives 1,700-5,800 peptides per run, enough for
the source proteins to speak:
NOD2_3 Prss16 x3, Psmb11 x1 4 acinar peptides -> thymus
NOD4 no thymus-exclusive 160 acinar peptides -> pancreas
NOD5 no thymus-exclusive 145 acinar peptides -> pancreas
The call is on presence, not a ratio. Prss16 (thymus-specific serine protease) and Psmb11
(thymoproteasome beta-5t, cortical thymic epithelium) have no tissue of expression outside
thymus, so a peptide from either cannot have been eluted from pancreas. A ratio would have
got this wrong: on a 3x rule NOD2_3 reads "unresolved" at 11 vs 4 while carrying three
Prss16 peptides.
An earlier marker set inflated the thymic signal in both pancreas runs because it counted
Krt5/Krt8/Krt14 -- generic epithelial keratins outside a thymus context -- and Lck/Zap70/
Tcf7, which mark the T-cell infiltrate that is the defining lesion of the NOD pancreas.
Those are now explicitly excluded.
thymus_immunopeptidome_mmu.tsv.gz 4,969 -> 6,663 rows / 5,306 peptides
tissue_self_mmu.tsv.gz 46,334 -> 53,992 rows / 24,177 peptides
Pancreas goes from 355 distinct peptides to 8,013, a 22x increase in the tissue that
matters most for type 1 diabetes. Note the file now holds two strains: these are NOD
(H-2g7) against C57BL/6 elsewhere, keyed on dataset_origin, with mhc_a empty because the
IP used the pan-H-2 antibody M1/42.
Co-Authored-By: Claude Opus 5 <noreply@anthropic.com>
- DESCRIPTION.md +7 -4
- ligandome/SOURCES.md +17 -2
- ligandome/tissue_self_mmu.tsv.gz +2 -2
- thymus/SOURCES.md +59 -13
- thymus/thymus_immunopeptidome_mmu.tsv.gz +2 -2
|
@@ -47,8 +47,11 @@ self-similarity use is peptide-level.
|
|
| 47 |
carries the mouse side, from three deposits: the thymus slice of the Schuster murine MHC-I tissue
|
| 48 |
atlas (PXD008733) and sorted cTEC/mTEC (PXD042241), with a third β a re-search of the Nanaware
|
| 49 |
I-Ab thymic raw spectra (MSV000087031), the only source of mouse **class II** thymic ligands β
|
| 50 |
-
still running and **not yet in this revision**.
|
| 51 |
-
|
|
|
|
|
|
|
|
|
|
| 52 |
Trans-Proteomic Pipeline PSM tables alongside the raw spectra, with `DECOY_` entries to recompute
|
| 53 |
the FDR from and the immunoprecipitating antibody encoded in the run name, so `mhc_a` is populated
|
| 54 |
there (`H-2Kb` / `H-2Db` / `I-Ab`, as-reported, never predicted). Its other 18 tissues are deposited
|
|
@@ -104,12 +107,12 @@ Every tracked directory now carries one:
|
|
| 104 |
| `proteome/mouse.fasta.gz` | Mouse proteome (UP000000589) | C57BL/6 self-reference proteome |
|
| 105 |
| `proteome/*_UP*.fasta.gz` | 16 bacterial + viral reference proteomes | foreign-antigen references for molecular-mimicry scans and peptide-flank extraction; see `proteome/README.md` |
|
| 106 |
| `thymus/thymus_immunopeptidome.tsv.gz` | Thymus self-peptidome (human) | HLA Ligand Atlas thymus-eluted self peptides (25.9k MHC-I + 28.0k MHC-II) β central-tolerance "self" reference for seqtree; fills the mislabeled source #1 |
|
| 107 |
-
| `thymus/thymus_immunopeptidome_mmu.tsv.gz` | Thymus self-peptidome (mouse) |
|
| 108 |
| `thymus/thymus_expression.tsv.gz` | Thymus expression (human) | thymically expressed self: HPA thymus-cluster genes (126) + atlas thymus source proteins (10.4k) |
|
| 109 |
| `ligandome/viral_foreign_iedb.tsv.gz` | Viral ligandome (IEDB) | viral-source presented peptides (foreign reference) |
|
| 110 |
| `ligandome/viral_orfs_gse272406.tsv.gz` | Pan-viral ORFs (GSE272406) | translated novel viral ORF proteins (foreign; *not* thymus self β spec mislabel) |
|
| 111 |
| `ligandome/cancer_targets_tsarina.tsv.gz` | Cancer-testis antigens | curated shared tumor-antigen genes (tsarina) |
|
| 112 |
-
| `ligandome/tissue_self_mmu.tsv.gz` | Tissue self-ligandome (mouse) |
|
| 113 |
| `expression/reference_expression.tsv.gz` | Reference expression (human) | 6,681,814 rows over three sources: `gtex` (3,955,284 / 53 tissues), **`hpa_consensus` (1,025,751 / 51 tissues β the only one containing thymus, added 2026-08-21)** and `tcga` (1,700,779 / 19 tumour types). GTEx has no thymus, lymph node or bone marrow |
|
| 114 |
| `expression/reference_expression_mmu.tsv.gz` | Reference expression (mouse) | 659,050 rows / 18,830 genes across **35 adult tissues**, `source=fantom5_mouse`. Column for column identical to the human file β the mouse GTEx analogue, the normal-tissue safety read for a mouse epitope. FANTOM5 CAGE (E-MTAB-3579). `n`=1 per tissue: the IQR is across transcripts, not animals |
|
| 115 |
| `expression/protein_abundance_mmu.tsv.gz` | Protein abundance (mouse) | 133,848 rows / 5,148 genes across 26 tissues, `source=geiger_silac_mouse`, `unit=ppb_ibaq` (E-PROT-11). Kept apart from the RNA table on purpose β a SILAC abundance is not a TPM |
|
|
|
|
| 47 |
carries the mouse side, from three deposits: the thymus slice of the Schuster murine MHC-I tissue
|
| 48 |
atlas (PXD008733) and sorted cTEC/mTEC (PXD042241), with a third β a re-search of the Nanaware
|
| 49 |
I-Ab thymic raw spectra (MSV000087031), the only source of mouse **class II** thymic ligands β
|
| 50 |
+
still running and **not yet in this revision**. A fourth deposit, PXD031966, joined once its tissue
|
| 51 |
+
labels were settled: its runs are named `NOD2_3`/`NOD4`/`NOD5` and name no tissue, so the re-search
|
| 52 |
+
was used to decide β `NOD2_3` carries `Prss16` and `Psmb11`, which have no tissue of expression
|
| 53 |
+
outside thymus, while `NOD4` and `NOD5` carry the exocrine zymogen program and no thymus-exclusive
|
| 54 |
+
protein at all. PXD008733 turned out **not** to require reprocessing after all β it ships
|
| 55 |
Trans-Proteomic Pipeline PSM tables alongside the raw spectra, with `DECOY_` entries to recompute
|
| 56 |
the FDR from and the immunoprecipitating antibody encoded in the run name, so `mhc_a` is populated
|
| 57 |
there (`H-2Kb` / `H-2Db` / `I-Ab`, as-reported, never predicted). Its other 18 tissues are deposited
|
|
|
|
| 107 |
| `proteome/mouse.fasta.gz` | Mouse proteome (UP000000589) | C57BL/6 self-reference proteome |
|
| 108 |
| `proteome/*_UP*.fasta.gz` | 16 bacterial + viral reference proteomes | foreign-antigen references for molecular-mimicry scans and peptide-flank extraction; see `proteome/README.md` |
|
| 109 |
| `thymus/thymus_immunopeptidome.tsv.gz` | Thymus self-peptidome (human) | HLA Ligand Atlas thymus-eluted self peptides (25.9k MHC-I + 28.0k MHC-II) β central-tolerance "self" reference for seqtree; fills the mislabeled source #1 |
|
| 110 |
+
| `thymus/thymus_immunopeptidome_mmu.tsv.gz` | Thymus self-peptidome (mouse) | 6,663 rows / 5,306 distinct peptides, `mhc_species=MusMusculus`, from three deposits. Whole thymus H-2Kb (1,089) + H-2Db (1,574) from the Schuster atlas PSM tables at a recomputed 1% peptide FDR; 2,304 from sorted cTEC/mTEC (PXD042241); 1,694 from NOD whole thymus (PXD031966, re-searched). `mhc_a` is as-reported from the IP antibody, never predicted. The MHC-II (I-Ab) arm is pending |
|
| 111 |
| `thymus/thymus_expression.tsv.gz` | Thymus expression (human) | thymically expressed self: HPA thymus-cluster genes (126) + atlas thymus source proteins (10.4k) |
|
| 112 |
| `ligandome/viral_foreign_iedb.tsv.gz` | Viral ligandome (IEDB) | viral-source presented peptides (foreign reference) |
|
| 113 |
| `ligandome/viral_orfs_gse272406.tsv.gz` | Pan-viral ORFs (GSE272406) | translated novel viral ORF proteins (foreign; *not* thymus self β spec mislabel) |
|
| 114 |
| `ligandome/cancer_targets_tsarina.tsv.gz` | Cancer-testis antigens | curated shared tumor-antigen genes (tsarina) |
|
| 115 |
+
| `ligandome/tissue_self_mmu.tsv.gz` | Tissue self-ligandome (mouse) | 53,992 rows / 24,177 distinct peptides over **18 non-thymic tissues**. Schuster murine MHC-I atlas (C57BL/6, recomputed 1% peptide FDR) plus 7,658 NOD pancreas peptides from the PXD031966 re-search, which takes pancreas from 355 to 8,013. Two strains, keyed on `dataset_origin` |
|
| 116 |
| `expression/reference_expression.tsv.gz` | Reference expression (human) | 6,681,814 rows over three sources: `gtex` (3,955,284 / 53 tissues), **`hpa_consensus` (1,025,751 / 51 tissues β the only one containing thymus, added 2026-08-21)** and `tcga` (1,700,779 / 19 tumour types). GTEx has no thymus, lymph node or bone marrow |
|
| 117 |
| `expression/reference_expression_mmu.tsv.gz` | Reference expression (mouse) | 659,050 rows / 18,830 genes across **35 adult tissues**, `source=fantom5_mouse`. Column for column identical to the human file β the mouse GTEx analogue, the normal-tissue safety read for a mouse epitope. FANTOM5 CAGE (E-MTAB-3579). `n`=1 per tissue: the IQR is across transcripts, not animals |
|
| 118 |
| `expression/protein_abundance_mmu.tsv.gz` | Protein abundance (mouse) | 133,848 rows / 5,148 genes across 26 tissues, `source=geiger_silac_mouse`, `unit=ppb_ibaq` (E-PROT-11). Kept apart from the RNA table on purpose β a SILAC abundance is not a TPM |
|
|
@@ -152,10 +152,10 @@ Mouse **self** peptides eluted from 18 normal tissues β the non-thymic counter
|
|
| 152 |
|
| 153 |
| | |
|
| 154 |
|---|---|
|
| 155 |
-
| rows | **
|
| 156 |
| columns | `peptide`, `mhc_a`, `mhc_class`, `mhc_species`, `source_protein`, `species`, `tissue`, `dataset_origin` |
|
| 157 |
| class | MHC-I 13,139 distinct Β· MHC-II 4,348 distinct |
|
| 158 |
-
| host | MusMusculus, 100%
|
| 159 |
| alleles | `H-2Kb`, `H-2Db` (MHC-I) Β· `I-Ab` (MHC-II) |
|
| 160 |
| tissues | 18 |
|
| 161 |
| provenance | **experimental** β MS-eluted ligands; identifications and the FDR cutoff **derived** |
|
|
@@ -190,7 +190,22 @@ which allele, in tissue a T cell can reach. Paired with the thymic deposit it se
|
|
| 190 |
different tolerance arguments: met during negative selection (thymus) versus reachable in the
|
| 191 |
periphery (here).
|
| 192 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 193 |
**Caveats.**
|
|
|
|
|
|
|
| 194 |
- Cell lines in the source atlas (EL4, B16F10, GL261, LLC/LLC1/LLC2) are **excluded** β tumour
|
| 195 |
lines, not normal tissue.
|
| 196 |
- Coverage is very uneven, and it is sampling depth, not biology: small_intestine carries 5,635
|
|
|
|
| 152 |
|
| 153 |
| | |
|
| 154 |
|---|---|
|
| 155 |
+
| rows | **53,992** (24,177 distinct peptides) |
|
| 156 |
| columns | `peptide`, `mhc_a`, `mhc_class`, `mhc_species`, `source_protein`, `species`, `tissue`, `dataset_origin` |
|
| 157 |
| class | MHC-I 13,139 distinct Β· MHC-II 4,348 distinct |
|
| 158 |
+
| host | MusMusculus, 100% β **two strains**: C57BL/6 (PXD008733) and NOD (PXD031966 pancreas) |
|
| 159 |
| alleles | `H-2Kb`, `H-2Db` (MHC-I) Β· `I-Ab` (MHC-II) |
|
| 160 |
| tissues | 18 |
|
| 161 |
| provenance | **experimental** β MS-eluted ligands; identifications and the FDR cutoff **derived** |
|
|
|
|
| 190 |
different tolerance arguments: met during negative selection (thymus) versus reachable in the
|
| 191 |
periphery (here).
|
| 192 |
|
| 193 |
+
### The NOD pancreas arm β `pride_pxd031966_pancreas`
|
| 194 |
+
|
| 195 |
+
7,658 peptides, added 2026-08-21 from the PXD031966 re-search. `NOD4` and `NOD5` carry 160 and 145
|
| 196 |
+
acinar zymogen peptides and **no thymus-exclusive protein at all**, while the third run of that
|
| 197 |
+
deposit carries `Prss16` and `Psmb11` and went to `thymus/`; the rule and its evidence are in
|
| 198 |
+
`thymus/SOURCES.md`. This takes pancreas from 355 distinct peptides to 8,013 β a 22Γ increase in the
|
| 199 |
+
tissue that matters most for type 1 diabetes.
|
| 200 |
+
|
| 201 |
+
**Read `dataset_origin` before pooling.** These are **NOD** mice (H-2^g7: K^d, D^b), not the
|
| 202 |
+
C57BL/6 (K^b, D^b) of the rest of the file, and `mhc_a` is empty because the immunoprecipitation used
|
| 203 |
+
the pan-H-2 antibody M1/42.3.9.8. Their FDR is mhcquant's 1% peptide-level, not the recomputed
|
| 204 |
+
iProphet cutoff used for the atlas.
|
| 205 |
+
|
| 206 |
**Caveats.**
|
| 207 |
+
- **Two strains and two FDR regimes live in this file**, keyed on `dataset_origin`. Pancreas in
|
| 208 |
+
particular is a mixture: 355 C57BL/6 peptides and 7,658 NOD ones.
|
| 209 |
- Cell lines in the source atlas (EL4, B16F10, GL261, LLC/LLC1/LLC2) are **excluded** β tumour
|
| 210 |
lines, not normal tissue.
|
| 211 |
- Coverage is very uneven, and it is sampling depth, not biology: small_intestine carries 5,635
|
|
@@ -1,3 +1,3 @@
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:
|
| 3 |
-
size
|
|
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
+
oid sha256:34462bddd798399f51caa30a8f899a2b24cdaddf9d2aaef009942cfd803f28cb
|
| 3 |
+
size 788062
|
|
@@ -32,14 +32,15 @@ foreign ones β see `mhcmatch.mimics.KINDS`.
|
|
| 32 |
Same schema, column for column. `mhc_species = species = MusMusculus` throughout. Added 2026-08-21;
|
| 33 |
this file is what the `## Not here` block of this document used to say was impossible.
|
| 34 |
|
| 35 |
-
**
|
| 36 |
|
| 37 |
-
| `dataset_origin` | `mhc_class` | `mhc_a` |
|
| 38 |
-
|---|---|---|--:|
|
| 39 |
-
| `pride_pxd008733_thymus` | MHCI | `H-2Db` | 1,574 |
|
| 40 |
-
| `pride_pxd008733_thymus` | MHCI | `H-2Kb` | 1,089 |
|
| 41 |
-
| `pride_pxd008733_thymus` | MHCII | `I-Ab` | 2 |
|
| 42 |
-
| `
|
|
|
|
| 43 |
|
| 44 |
MHC-I lengths run 8β11 with a median of 9. The two MHC-II rows are all that survive the 11β25 window
|
| 45 |
from PXD008733's 16 thymic anti-I-A/I-E PSMs β that immunoprecipitation returned mostly 9β10mers,
|
|
@@ -92,6 +93,55 @@ Source proteins in this deposit are Ensembl and transposable-element identifiers
|
|
| 92 |
mTEC/cTEC database, so peptides derived from non-canonical ORFs carry an empty `source_protein`
|
| 93 |
after re-mapping.
|
| 94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 95 |
### `massive_msv000087031_thymus` β I-Ab, the MHC class II arm β **pending, not in this revision**
|
| 96 |
|
| 97 |
The only source of mouse **class II** thymic ligands. No identifications were deposited, so this arm
|
|
@@ -175,12 +225,8 @@ archive. Bulk data cannot substitute β `Aire` itself reads 0 TPM in whole thym
|
|
| 175 |
confined to a rare mTEC subset, so the promiscuous-expression question needs sorted mTEC, not this
|
| 176 |
file. **Absent, not overlooked.**
|
| 177 |
|
| 178 |
-
**PXD031966 is
|
| 179 |
-
|
| 180 |
-
`NOD4`, `NOD5`) name neither, PMID 36210013 is closed-access with no PMC copy, and its deposited
|
| 181 |
-
tables give 30β50 peptides per run β too few for the pancreatic acinar signature
|
| 182 |
-
(Cela/Prss/Cpa/Ctrb/Pnlip) to separate the two. Its peptides will not be labelled `thymus` on a
|
| 183 |
-
guess. See `~/vcs/projects/2026-mouse-thymus/SOURCES.md`.
|
| 184 |
|
| 185 |
## Re-fetch / regenerate
|
| 186 |
|
|
|
|
| 32 |
Same schema, column for column. `mhc_species = species = MusMusculus` throughout. Added 2026-08-21;
|
| 33 |
this file is what the `## Not here` block of this document used to say was impossible.
|
| 34 |
|
| 35 |
+
**6,663 rows / 5,306 distinct peptides** as deposited here.
|
| 36 |
|
| 37 |
+
| `dataset_origin` | `mhc_class` | `mhc_a` | peptides |
|
| 38 |
+
|---|---|---|--:|
|
| 39 |
+
| `pride_pxd008733_thymus` | MHCI | `H-2Db` | 1,574 |
|
| 40 |
+
| `pride_pxd008733_thymus` | MHCI | `H-2Kb` | 1,089 |
|
| 41 |
+
| `pride_pxd008733_thymus` | MHCII | `I-Ab` | 2 |
|
| 42 |
+
| `pride_pxd031966_thymus` | MHCI | *(empty)* | 1,694 |
|
| 43 |
+
| `pride_pxd042241_tec` | MHCI | *(empty)* | 2,304 |
|
| 44 |
|
| 45 |
MHC-I lengths run 8β11 with a median of 9. The two MHC-II rows are all that survive the 11β25 window
|
| 46 |
from PXD008733's 16 thymic anti-I-A/I-E PSMs β that immunoprecipitation returned mostly 9β10mers,
|
|
|
|
| 93 |
mTEC/cTEC database, so peptides derived from non-canonical ORFs carry an empty `source_protein`
|
| 94 |
after re-mapping.
|
| 95 |
|
| 96 |
+
### `pride_pxd031966_thymus` β NOD mouse, whole thymus
|
| 97 |
+
|
| 98 |
+
The NOD-mouse MHC-I deposit covers thymus *and* pancreas, and **its run labels name neither**:
|
| 99 |
+
`NOD2_3`, `NOD4`, `NOD5`. PMID 36210013 is closed-access with no PMC copy, and the deposited tables
|
| 100 |
+
give only 30β50 peptides per run, far too few to tell the two apart. This was recorded here as an
|
| 101 |
+
open labelling problem, and its peptides were deliberately withheld rather than guessed.
|
| 102 |
+
|
| 103 |
+
The re-search settled it. Searching the nine raw files against the whole mouse proteome (rather than
|
| 104 |
+
the deposit's own predicted-binder FASTA) gives 1,700β5,800 peptides per run β enough for the source
|
| 105 |
+
proteins to speak:
|
| 106 |
+
|
| 107 |
+
| run | thymus-exclusive proteins | acinar zymogen peptides | call |
|
| 108 |
+
|---|---|--:|---|
|
| 109 |
+
| `NOD2_3` | **`Prss16` Γ3, `Psmb11` Γ1** | 4 | **thymus** |
|
| 110 |
+
| `NOD4` | none | 160 | pancreas |
|
| 111 |
+
| `NOD5` | none | 145 | pancreas |
|
| 112 |
+
|
| 113 |
+
**The call is made on presence, not on a ratio.** `Prss16` is the thymus-specific serine protease and
|
| 114 |
+
`Psmb11` the thymoproteasome subunit Ξ²5t, confined to cortical thymic epithelium; neither has a
|
| 115 |
+
tissue of expression outside thymus in the mouse, so a peptide from either cannot have been eluted
|
| 116 |
+
from pancreas. The converse holds for the exocrine zymogen program. A ratio is the wrong instrument
|
| 117 |
+
and would have got this wrong β on a 3Γ rule `NOD2_3` reads "unresolved" at 11 thymic against 4
|
| 118 |
+
pancreatic markers, while carrying three `Prss16` peptides and a `Psmb11` one.
|
| 119 |
+
|
| 120 |
+
An earlier, looser marker set inflated the thymic signal in *both* pancreas runs, because it counted
|
| 121 |
+
`Krt5`/`Krt8`/`Krt14` β thymic-epithelium markers in a thymus context but generic epithelial keratins
|
| 122 |
+
elsewhere β and `Lck`/`Zap70`/`Tcf7`, which mark the T-cell infiltrate that is the defining lesion of
|
| 123 |
+
the NOD pancreas. Those genes are now explicitly excluded; the rule is in
|
| 124 |
+
`src/assign_pxd031966_tissue.py`.
|
| 125 |
+
|
| 126 |
+
Only `NOD2_3` is deposited here. `NOD4` and `NOD5` are in `ligandome/tissue_self_mmu.tsv.gz` as
|
| 127 |
+
pancreas.
|
| 128 |
+
|
| 129 |
+
> Wang L, Li X, Yang S, Chen X, Li J, Wang S, Zhang M, Zheng Z, Zhou J, Wang L, Wu Y.
|
| 130 |
+
> **Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic
|
| 131 |
+
> mouse thymus and pancreas.**
|
| 132 |
+
> *J Proteomics* 2022;270:104746.
|
| 133 |
+
> PMID [36210013](https://pubmed.ncbi.nlm.nih.gov/36210013/) Β·
|
| 134 |
+
> doi:[10.1016/j.jprot.2022.104746](https://doi.org/10.1016/j.jprot.2022.104746)
|
| 135 |
+
|
| 136 |
+
`mhc_a` is empty: the immunoprecipitation used the pan-H-2 antibody M1/42.3.9.8, which resolves no
|
| 137 |
+
allele. NOD is H-2^g7 (K^d, D^b), so these peptides are **not** C57BL/6 K^b/D^b ligands β read
|
| 138 |
+
`dataset_origin` before pooling them with the PXD008733 rows.
|
| 139 |
+
|
| 140 |
+
**Re-searched, not taken as deposited.** The authors searched a predicted-MHC-binder FASTA at 5% PSM
|
| 141 |
+
FDR; a database of peptides someone already predicted to bind can only return peptides someone
|
| 142 |
+
already predicted to bind. This is nf-core/mhcquant 3.2.0 against UP000000589 at 1% peptide-level
|
| 143 |
+
FDR.
|
| 144 |
+
|
| 145 |
### `massive_msv000087031_thymus` β I-Ab, the MHC class II arm β **pending, not in this revision**
|
| 146 |
|
| 147 |
The only source of mouse **class II** thymic ligands. No identifications were deposited, so this arm
|
|
|
|
| 225 |
confined to a rare mTEC subset, so the promiscuous-expression question needs sorted mTEC, not this
|
| 226 |
file. **Absent, not overlooked.**
|
| 227 |
|
| 228 |
+
**PXD031966 is now here, and the tissue labels were settled by measurement.** See the
|
| 229 |
+
`pride_pxd031966_thymus` section above.
|
|
|
|
|
|
|
|
|
|
|
|
|
| 230 |
|
| 231 |
## Re-fetch / regenerate
|
| 232 |
|
|
@@ -1,3 +1,3 @@
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:
|
| 3 |
-
size
|
|
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
+
oid sha256:f93e0c1a974155081fec64d03948f691eed6631f2aed25e5286a8c705e1ea157
|
| 3 |
+
size 103810
|